Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
MARBOFLOXACIN
Vetoquinol Ireland Limited
QJ01MA93
MARBOFLOXACIN
2 %w/v
Solution for Injection
POM
Bovine, Porcine
Marbofloxacin
Antibacterial
Authorised
1998-09-18
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Marbocyl 2% w/v Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Solution for injection. A yellow-greenish to yellow-brownish solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pre- ruminating and ruminating calves and pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In Calves Marbofloxacin 2% is indicated in the treatment of respiratory infections caused by susceptible strains of organisms. In Pigs Marbofloxacin 2% is indicated in the treatment of respiratory infections caused by susceptible strains of organisms and in the treatment of Metritis Mastitis Agalactia (MMA) syndrome caused by susceptible strains of organisms. 4.3 CONTRAINDICATIONS Do not use in known cases of hypersensitivity to the active ingredient. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Each ml contains: ACTIVE SUBSTANCE Marbofloxacin 20.0 mg EXCIPIENTS Metacresol 2.0 mg Monothioglycerol 0.5 mg For a full list of excipients, see section 6.1 HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 19/10/2016_ _CRN 7023455_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials. Whenever possible, fluoroquinolones should only be used based on susceptibility testing. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolone Read the complete document